OptiCare Reports Fourth Quarter and Year End 2004 Financial Results WATERBURY, Conn., March 31 /PRNewswire-FirstCall/ -- OptiCare Health Systems, Inc. (AMEX:OPT) announced today for the fourth quarter ended December 31, 2004, total net revenue on a continuing operations basis increased approximately 3.9% to $14,378,000 from $13,842,000 in the same period in 2003. For the full year, total net revenue on a continuing operations basis decreased approximately 3.6% to $58,903,000 from approximately $61,099,000 in 2003. Results from continuing operations exclude the Company's Distribution Segment which was sold on January 12, 2005. OptiCare also reported income from continuing operations for the fourth quarter ended December 31, 2004 of $286,000 compared to a loss of $640,000 for the fourth quarter 2003. For the year ended December 31, 2004, OptiCare reported income from continuing operations of $38,000 compared to a loss from continuing operations of $7,053,000 for the year ended December 31, 2003. The loss in 2003 resulted primarily from a one-time charge of $1,896,000 related to an early extinguishment of debt and the write-off of $4,927,000 in deferred tax assets. "Our 2004 operating results demonstrate that the Company continues to focus on its core businesses of Consumer Vision and Managed Vision and has established a solid foundation to build upon," stated, Christopher J. Walls, OptiCare's President and Chief Executive Officer. In addition, on January 12, 2005, OptiCare closed a series of transactions which resulted in a significant debt reduction while increasing its equity. Taken together, these transactions lowered OptiCare's long-term debt and accounts payable by approximately $6,145,000 and $1,530,000, respectively, and increased its equity by approximately $4,445,000. The transactions included, among other things, the following: * Palisade Concentrated Equity Partnership, L.P., OptiCare's majority stockholder, and Linda Yimoyines, the spouse of OptiCare's Chairman and former Chief Executive Officer, purchased for approximately $4,445,000 of OptiCare's Series D Preferred Stock; * OptiCare sold, effective December 31, 2004, substantially all of the assets and certain liabilities of its Distribution Division, which consisted of Wise Optical and its Optical Buying Group, for an aggregate purchase price of approximately $4,150,000, less a working capital adjustment of approximately $575,000 and closing costs of approximately $349,000, to Wise Optical, LLC and AECC/Pearlman Buying Group, LLC, both entities formed by OptiCare's Chairman and former Chief Executive Officer; and * OptiCare amended the terms of its revolving credit, term loan and security agreement with OptiCare's senior lender, to reduce the tangible net worth covenant for December 2004 and January 2005 from ($3,000,000) to ($6,500,000). Without this amendment, OptiCare would have been in violation of the tangible net worth covenant at December 31, 2004. Under the revolving credit, term loan and security agreement, as amended; OptiCare must maintain a tangible net worth of at least ($3,000,000) million after February 1, 2005. "The recent sale of our Distribution Segment and the issuance of the Series D Preferred Stock significantly lowered our debt, increased stockholders' equity and will reduce our debt service on a prospective basis which should improve the Company's financial performance in 2005," stated Mr. Walls. About OptiCare Health Systems, Inc. OptiCare Health Systems, Inc. is an integrated eye care services company focused on vision benefits management and consumer vision services, including medical, surgical and optometric services and optical retail. This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding OptiCare's 2005 operating or financial performance. OptiCare's actual results could differ materially from those expressed or indicated by any forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the risk that OptiCare may not retain and attract qualified employees, OptiCare may not realize one or more of the expected benefits and efficiencies of the transaction including its debt reduction or equity investment, the impact of current and future governmental regulations, OptiCare's ability to successfully and profitably manage its operations, and growth of the operations, if any, the risks related to managed care contracting, and the ability of OptiCare to successfully raise capital on commercially reasonable terms, if at all. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in OptiCare's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ending December 31, 2004. Forward-looking statements speak only as of the date they are made, and OptiCare undertakes no duty or obligation to update any forward-looking statements in light of new information or future events. OptiCare Health Systems, Inc. And Subsidiaries Consolidated Balance Sheets (Amounts In Thousands, Except Share And Per Share Data) December 31, 2004 2003 ASSETS CURRENT ASSETS: Cash and cash equivalents $2,228 $1,695 Accounts receivable, net 2,164 2,044 Inventories 1,851 1,773 Assets held for sale 7,894 11,578 Notes receivable 82 105 Other current assets 599 354 Total Current Assets 14,818 17,549 Property and equipment, net 2,628 2,761 Goodwill 16,663 16,565 Intangible assets, net 1,068 1,179 Assets held for sale, non-current 1,150 4,670 Deferred debt issuance costs, net 342 398 Notes receivable, less current portion 734 791 Restricted cash 1,413 1,158 Other assets 998 784 TOTAL ASSETS $ 39,814 $45,855 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable 2,727 734 Claims payable and claims incurred but not reported 1,897 1,534 Accrued salaries and related expenses 2,743 2,186 Accrued expenses 1,874 1,184 Current portion of long-term debt 332 10,818 Current portion of capital lease obligations 11 10 Liabilities of held for sale business 5,683 6,755 Other current liabilities 1,119 407 Total Current Liabilities 16,386 23,628 NON-CURRENT LIABILITIES: Long-term debt, less current portion 10,024 1,775 Capital lease obligations, less current portion 19 -- Other liabilities 1,476 405 Total Non-Current Liabilities 11,519 2,180 COMMITMENTS AND CONTINGENCIES (Notes 10, 12, and 19) SERIES B 12.5% REDEEMABLE, CONVERTIBLE PREFERRED STOCK AT AGGREGATE LIQUIDATION PREFERENCE-RELATED PARTY 6,344 5,635 STOCKHOLDERS' EQUITY: Series C Preferred Stock, $.001 par value ($16,251 aggregate liquidation preference); 406,158 shares issued and outstanding at December 31, 2004 and December 31, 2003, respectively 1 1 Common Stock, $0.001 par value; 150,000,000 shares authorized; 30,638,283 and 30,386,061 shares issued and outstanding at December 31, 2004 and 2003, respectively 31 30 Additional paid-in-capital 79,192 79,700 Accumulated deficit (73,659) (65,319) TOTAL STOCKHOLDERS' EQUITY 5,565 14,412 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $39,814 $45,855 OptiCare Health Systems, Inc. And Subsidiaries Condensed Consolidated Statements Of Operations (Amounts In Thousands, Except Share Data) Three Months Twelve Months Ended December 31, Ended December 31, 2004 2003 2004 2003 (Unaudited) NET REVENUES: Managed vision $ 6,631 $ 6,104 $25,495 $ 28,111 Product sales 2,649 2,745 11,580 11,295 Other services 4,635 4,989 19,907 18,971 Other income 463 4 1,921 2,722 Total net revenues 14,378 13,842 58,903 61,099 OPERATING EXPENSES: Medical claims expense 4,882 4,749 19,156 22,000 Cost of product sales 927 1,056 4,128 3,837 Cost of services 1,948 2,080 8,322 8,001 Selling, general and administrative 5,777 5,842 25,053 24,165 Loss from early extinguishment of debt -- 48 -- 1,896 Depreciation 203 335 848 1,168 Amortization 31 27 117 114 Interest 304 330 1,190 2,044 Total operating expenses 14,072 14,467 58,814 63,225 Income (loss) from continuing operations before tax 306 (625) 89 (2,126) Income tax expense 20 15 51 4,927 Income (loss) from continuing operations 286 (640) 38 (7,053) Discontinued operations: Loss from discontinued operations, net of income tax (1,131) (1,220) (3,973) (5,300) Loss on disposal of discontinued operations (3,401) -- (4,405) -- Loss from discontinued operations (4,532) (1,220) (8,378) (5,300) Net loss (4,246) (1,860) (8,340) (12,353) Preferred stock dividends (181) (159) (709) (618) Net loss available to common stockholders $ (4,427) $ (2,019) $(9,049) $ (12,971) EARNINGS (LOSS) PER SHARE: Income (loss) from continuing operations: Basic $0.00 $ (0.03) $ (0.02) $ (0.25) Diluted $0.00 $ (0.03) $ (0.02) $ (0.25) Loss from discontinued operations: Basic $ (0.15) $ (0.04) $ (0.28) $ (0.18) Diluted $ (0.15) $ (0.04) $ (0.28) $ (0.18) Net loss: Basic $ (0.14) $ (0.07) $ (0.30) $ (0.43) Diluted $ (0.14) $ (0.07) $ (0.30) $ (0.43) DATASOURCE: OptiCare Health Systems, Inc. CONTACT: William A. Blaskiewicz, Chief Financial Officer of OptiCare Health Systems, Inc., +1-203-596-2236

Copyright

Opticare Health (AMEX:OPT)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024 Opticare Health 차트를 더 보려면 여기를 클릭.
Opticare Health (AMEX:OPT)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024 Opticare Health 차트를 더 보려면 여기를 클릭.